Gastric secretory inhibitors such as proton pump inhibitors and histamine H2-receptor antagonists are known to affect the gastrointestinal pH and are used to treat peptic ulcer and gastroesophageal reflux disease and eradicate Helicobacter pylori. Here, HRH2 is linked to peptic ulcer disease.